Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02535806
Title Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Mercy Hospital Kansas City
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Mercy Hospital Kansas City Missouri 64108 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field